Evaluation of anorganic bovine-derived hydroxyapatite matrix/cell binding peptide as a bone graft material in the treatment of human periodontal infrabony defects: A clinico-radiographic study
Ghousia Fatima, Ravindra Shivamurthy, Srinath Thakur, Mohammad Abdul Baseer, Ghousia Fatima, Ravindra Shivamurthy, Srinath Thakur, Mohammad Abdul Baseer
Abstract
Background: Various bone graft materials have been used in the treatment of periodontal defects. A synthetic bone substitute material composed of P-15 with anorganic bone mineral has been scantly studied. Hence, the present study was aimed to evaluate and compare the efficacy of anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) in human periodontal infrabony defects with that of open flap debridement (OFD) alone.
Materials and methods: A split-mouth, randomized controlled clinical study was designed to investigate the efficacy of ABM/P-15. In this clinical trial, 10 patients having bilateral periodontal infrabony defects were treated either with ABM/P-15 or OFD and followed for a period of 9 months. At baseline and at 9 months probing pocket depth (PPD), relative attachment level (RAL), depth of a defect, and radiographic bone level were measured; and compared between test and control sites.
Results: A statistically significant reduction (P < 0.001) in PPD was observed in test sites compared to control sites. Both sites showed a gain in RAL without any significant difference. Similarly, the radiographic evaluation revealed significantly higher radiographic defect fill in test sites as compared to control sites (P < 0.001).
Conclusion: ABM/P-15 bone graft material appears to be useful and beneficial in the treatment of human periodontal infrabony defects.
Keywords: Cell binding peptide P-15; grafts; hydroxyapatite; periodontal disease; periodontal regeneration.
Figures
References
- Rosenberg E, Rose LF. Biologic and clinical considerations for autografts and allografts in periodontal regeneration therapy. Dent Clin North Am. 1998;42:467–90.
- Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects 6-month results. J Periodontol. 2000;71:1671–9.
- Barboza EP, de Souza RO, Caúla AL, Neto LG, Caúla Fde O, Duarte ME. Bone regeneration of localized chronic alveolar defects utilizing cell binding peptide associated with anorganic bovine-derived bone mineral: A clinical and histological study. J Periodontol. 2002;73:1153–9.
- Lallier TE, Yukna R, St Marie S, Moses R. The putative collagen binding peptide hastens periodontal ligament cell attachment to bone replacement graft materials. J Periodontol. 2001;72:990–7.
- Emecen P, Akman AC, Hakki SS, Hakki EE, Demiralp B, Tözüm TF, et al. ABM/P-15 modulates proliferation and mRNA synthesis of growth factors of periodontal ligament cells. Acta Odontol Scand. 2009;67:65–73.
- Zander HA, Polson AM, Heijl LC. Goals of periodontal therapy. J Periodontol. 1976;47:261–6.
- Jiang D, Dziak R, Lynch SE, Stephan EB. Modification of an osteoconductive anorganic bovine bone mineral matrix with growth factors. J Periodontol. 1999;70:834–9.
- Richardson CR, Mellonig JT, Brunsvold MA, McDonnell HT, Cochran DL. Clinical evaluation of Bio-Oss: A bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol. 1999;26:421–8.
- Froum SJ, Coran M, Thaller B, Kushner L, Scopp IW, Stahl SS. Periodontal healing following open debridement flap procedures. I. Clinical assessment of soft tissue and osseous repair. J Periodontol. 1982;53:8–14.
- Stahl SS, Froum SJ, Kushner L. Periodontal healing following open debridement flap procedures. II. Histologic observations. J Periodontol. 1982;53:15–21.
- Pihlstrom BL. Measurement of attachment level in clinical trials: Probing methods. J Periodontol. 1992;63:1072–7.
- Barros RR, Novaes AB, Jr, Roriz VM, Oliveira RR, Grisi MF, Souza SL, et al. Anorganic bovine matrix/p-15 “flow” in the treatment of periodontal defects: Case series with 12 months of follow-up. J Periodontol. 2006;77:1280–7.
- Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans. J Periodontol. 2001;72:1157–63.
- Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M. Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. A controlled clinical study. J Clin Periodontol. 2003;30:73–80.
- Kasaj A, Röhrig B, Reichert C, Willershausen B. Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects. Clin Oral Investig. 2008;12:241–7.
- Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, et al. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects 6-month results. J Periodontol. 1998;69:655–63.
- Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings. J Periodontol. 2002;73:123–8.
- Yukna R, Salinas TJ, Carr RF. Periodontal regeneration following use of ABM/P-1 5: A case report. Int J Periodontics Restorative Dent. 2002;22:146–55.
- Radhakrishnan S, Anusuya CN. Comparative clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and open flap debridement (DEBR) in human periodontal osseous defects: A 6 month pilot study. J Int Acad Periodontol. 2004;6:101–7.
- Sogal A, Tofe AJ. Risk assessment of bovine spongiform encephalopathy transmission through bone graft material derived from bovine bone used for dental applications. J Periodontol. 1999;70:1053–63.
- Paolantonio M. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study. J Periodontol. 2002;73:158–66.
- Klein F, Kim TS, Hassfeld S, Staehle HJ, Reitmeir P, Holle R, et al. Radiographic defect depth and width for prognosis and description of periodontal healing of infrabony defects. J Periodontol. 2001;72:1639–46.
- Liñares A, Cortellini P, Lang NP, Suvan J, Tonetti MS. European Research Group on Periodontology (ErgoPerio). Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: Radiographic predictors and outcomes. J Clin Periodontol. 2006;33:351–8.
- Tonetti MS, Cortellini P, Lang NP, Suvan JE, Adriaens P, Dubravec D, et al. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial. J Clin Periodontol. 2004;31:770–6.
- Tsitoura E, Tucker R, Suvan J, Laurell L, Cortellini P, Tonetti M. Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative. J Clin Periodontol. 2004;31:643–7.
- Gottlow J, Nyman S, Lindhe J, Karring T, Wennström J. New attachment formation in the human periodontium by guided tissue regeneration. Case reports. J Clin Periodontol. 1986;13:604–16.
- Khashu H, Vandana KL. Clinical and radiographic evaluation of human periodontal osseous defect (mandibular grade II furcation) treated with PepGen P-15 and a bioresorbable membrane (Atrisorb) J Indian Soc Periodontol. 2012;16:569–76.
- Rabalais ML, Yukna RA, Mayer ET. Evaluation of durapatite ceramic as an alloplastic implant in periodontal osseous defects. 1. Initial 6 months results. J Clin Periodontol. 2000;71:752–9.
- Meffert RM, Thomas JR, Hamilton KM, Brownstein CN. Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol. 1985;56:63–73.
- Camargo PM, Lekovic V, Weinlaender M, Nedic M, Vasilic N, Wolinsky LE, et al. A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol. 2000;27:889–96.
- Krejci CB, Bissada NF, Farah C, Greenwell H. Clinical evaluation of porous and nonporous hydroxyapatite in the treatment of human periodontal bony defects. J Periodontol. 1987;58:521–8.
Source: PubMed